Cargando…
HBP1 inhibits the development of type 2 diabetes mellitus through transcriptional activation of the IGFBP1 gene
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that is highly prevalent worldwide and characterized by glucose and lipid metabolism disorders. However, the pathogenic mechanisms have not been fully established. Here, we found that HMG-box transcription factor 1 (HBP1) is involved in...
Autores principales: | Cheng, Yuning, Yang, Ruixiang, Zhou, Yue, Wang, Jiyin, Zhang, Tongjia, Wang, Shujie, Li, Hui, Jiang, Wei, Zhang, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699764/ https://www.ncbi.nlm.nih.gov/pubmed/36326689 http://dx.doi.org/10.18632/aging.204364 |
Ejemplares similares
-
The transcription factor HBP1 promotes ferroptosis in tumor cells by regulating the UHRF1-CDO1 axis
por: Yang, Ruixiang, et al.
Publicado: (2023) -
Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling
por: Wang, Jiyin, et al.
Publicado: (2022) -
HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression
por: Cao, Zhengyi, et al.
Publicado: (2021) -
MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1
por: Cao, Zhengyi, et al.
Publicado: (2019) -
Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma
por: Li, Hui, et al.
Publicado: (2021)